Lisanti Capital Growth, LLC SPRY ARS PHARMACEUTICALS INC

Ownership history in Lisanti Capital Growth, LLC  ·  4 quarters on record

AI Ownership Summary

Lisanti Capital Growth, LLC reported ARS PHARMACEUTICALS INC (SPRY) in 4 quarterly 13F filings from 2025 Q1 through 2025 Q4. Peak portfolio weight reached 2.03% in 2025 Q2. The latest visible filing shows SPRY at 1.09% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this SPRY ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Lisanti Capital Growth, LLC's position in ARS PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

SPRY was reported at 1.09% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
2.03% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Lisanti Capital Growth, LLC held SPRY — position size vs. price
% of Fund (quarterly)    SPRY price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED 396,509 +185,320 +87.8% 1.09% $4.6M 2026-02-09 $9.79
2025 Q3 REDUCED 49.7% +16.6% 211,189 -208,886 -49.7% 0.52% $2.1M 2025-11-04 $8.71
2025 Q2 ADDED 420,075 +226,245 +116.7% 2.03% $7.3M 2025-08-07 $17.65
2025 Q1 INITIATED 193,830 0.73% $2.4M 2025-04-25 $13.77

FAQ About Lisanti Capital Growth, LLC and SPRY

These are the practical questions this page is built to answer before you even open the full history table.

How long has Lisanti Capital Growth, LLC reported owning SPRY?

Lisanti Capital Growth, LLC reported SPRY across 4 quarterly 13F filings, from 2025 Q1 through 2025 Q4.

What was the largest reported SPRY position in Lisanti Capital Growth, LLC's portfolio?

The largest reported portfolio weight for SPRY was 2.03% in 2025 Q2.

What is the latest reported SPRY position on this page?

The most recent filing on this page is 2025 Q4, when Lisanti Capital Growth, LLC reported 396,509 shares, equal to 1.09% of portfolio, with an estimated market value of $4.6M.

What does the chart on this SPRY ownership page compare?

The chart compares Lisanti Capital Growth, LLC's quarterly SPRY portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Lisanti Capital Growth, LLC time their SPRY position?

Based on 13F filing dates vs. subsequent SPRY price moves, Lisanti Capital Growth, LLC correctly timed 1 out of 3 reported position changes (33%). The annualised alpha on SPRY relative to SPY over the holding period was -51.9%.

← Back to Lisanti Capital Growth, LLC Holdings